Humacyte, Inc. (HUMA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$105.04M | -7.1% |
| 2024 | -$98.12M | -33.9% |
| 2023 | -$73.31M | -3.1% |
| 2022 | -$71.13M | +12.4% |
| 2021 | -$81.19M | -46.1% |
| 2020 | -$55.57M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$105.04M | -7.1% |
| 2024 | -$98.12M | -33.9% |
| 2023 | -$73.31M | -3.1% |
| 2022 | -$71.13M | +12.4% |
| 2021 | -$81.19M | -46.1% |
| 2020 | -$55.57M | — |